Testing a wearable fluid removal device on dialysis patients
Part of Blood & lymphatic, Kidney & urinary clinical trials.
This trial tests a wearable device that may help remove extra fluid during or between dialysis sessions. It is for people on thrice-weekly hemodialysis who have trouble reaching their dry weight or have high fluid gains between treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have dialysis three times a week through a central vein catheter
- You have had either high fluid gains, trouble reaching your dry weight, or needed extra treatments to get to dry weight in the last month
- You do not have an active infection
- You have been following your dialysis schedule and prescription
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a sodium management tool can improve outcomes for people on hemodialysis. If you are on dialysis three times a week with a Fresenius 6008 machine, you may be able to join.
This trial tests whether removing extra fluid during your regular dialysis sessions can help lower high blood pressure and reduce symptoms of fluid buildup. You'll continue your normal three-times-a-week dialysis but with adjusted fluid removal amounts.
This trial tests whether adding a special blood-filtering device (hemoadsorption) to your regular dialysis treatment can reduce uncomfortable symptoms caused by kidney failure, like fatigue or itching. Researchers will track how you feel over time compared to standard dialysis alone.
This trial tests a wearable device that removes extra fluid from your body without using the kidneys. It may help people with heart failure who still have fluid buildup despite taking high doses of water pills.
This trial tests whether a faster rate of fluid removal during dialysis can help hospitalized patients with end-stage kidney disease who have severe fluid buildup. It aims to reduce fluid congestion and improve outcomes.
This study compares a specific way of removing fluid during dialysis (isolated ultrafiltration) with conventional hemodialysis. It aims to see how each approach affects blood flow and fluid shifts in people with end-stage kidney disease.
Hear when a new Hemodialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.